Xonabact 1000mg/500mg Powder for Injection
Marketer
Pollen Healthcure Pvt. Ltd.
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Xonabact 1000mg/500mg Powder for Injection
Combiflox, a 1000mg/500mg injectable powder, combats diverse bacterial infections. This dual-action medication inhibits microbial proliferation, halting infection spread. Administration must be overseen by a medical professional. Complete the prescribed regimen, even with symptom improvement; premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential drowsiness. While typically non-impairing, avoid driving if experiencing somnolence or vertigo. Adequate rest, nutrition, and hydration promote recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Xonabact 1000mg/500mg Powder for Injection
Managing Bacterial Infections
Major Benefits of Xonabact 1000mg/500mg Powder for Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Xonabact 1000mg/500mg Powder for Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Xonabact 1000mg/500mg Powder for Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not recommended.
How Xonabact 1000mg/500mg Powder for Injection works:
Xonabact, a 1000mg/500mg injectable powder, merges the actions of Cefoperazone, a bacterium-fighting antibiotic, and Sulbactam, a beta-lactamase inhibitor. Cefoperazone disrupts bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby improving Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during treatment with Xonabact 1000mg/500mg injectable powder can lead to adverse effects including facial redness, tachycardia, queasiness, dehydration, pectoral pain, and hypotension (a Disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable powder formulation of Xonabact (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human pregnancies remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Xonabact 1000mg/500mg Powder for Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no identified risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Xonabact 1000mg/500mg Powder for Injection on driving ability is unknown. Refrain from driving if you encounter symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Xonabact 1000mg/500mg injectable powder to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Xonabact 1000mg/500mg injectable powder to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Xonabact 1000mg/500mg Powder for Injection :
Omit a scheduled dose of Xonabact 1000mg/500mg injectable powder? Seek your physician's advice.
Facts to Know About Xonabact 1000mg/500mg Powder for Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |

